Literature DB >> 22561707

Healthcare-associated infection and hospital readmission.

Carley B Emerson1, Lindsay M Eyzaguirre, Jennifer S Albrecht, Angela C Comer, Anthony D Harris, Jon P Furuno.   

Abstract

OBJECTIVE: Hospital readmissions are a current target of initiatives to reduce healthcare costs. This study quantified the association between having a clinical culture positive for 1 of 3 prevalent hospital-associated organisms and time to hospital readmission.
DESIGN: Retrospective cohort study. PATIENTS AND
SETTING: Adults admitted to an academic, tertiary care referral center from January 1, 2001, through December 31, 2008.
METHODS: The primary exposure of interest was a clinical culture positive for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), or Clostridium difficile obtained more than 48 hours after hospital admission during the index hospital stay. The primary outcome of interest was time to readmission to the index facility. Multivariable Cox proportional hazards models were used to model the adjusted association between positive clinical culture result and time to readmission and to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).
RESULTS: Among 136,513 index admissions, the prevalence of hospital-associated positive clinical culture result for 1 of the 3 organisms of interest was 3%, and 35% of patients were readmitted to the index facility within 1 year after discharge. Patients with a positive clinical culture obtained more than 48 hours after hospital admission had an increased hazard of readmission (HR, 1.40; 95% CI, 1.33-1.46) after adjusting for age, sex, index admission length of stay, intensive care unit stay, Charlson comorbidity index, and year of hospital admission.
CONCLUSIONS: Patients with healthcare-associated infections may be at increased risk of hospital readmission. These findings may be used to impact health outcomes after discharge from the hospital and to encourage better infection prevention efforts.

Entities:  

Mesh:

Year:  2012        PMID: 22561707      PMCID: PMC3677598          DOI: 10.1086/665725

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

1.  Length of hospital stay and subsequent emergency readmission.

Authors:  Susan Williams; Alex Bottle; Paul Aylin
Journal:  BMJ       Date:  2005-08-13

2.  Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.

Authors:  Anthony D Harris; Jon P Furuno; Mary-Claire Roghmann; Jennifer K Johnson; Laurie J Conway; Richard A Venezia; Harold C Standiford; Marin L Schweizer; Joan N Hebden; Anita C Moore; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

3.  Risk factors for early emergency hospital readmission in elderly medical patients.

Authors:  L W Chu; C K Pei
Journal:  Gerontology       Date:  1999 Jul-Aug       Impact factor: 5.140

4.  Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference?

Authors:  E Toubes; K Singh; D Yin; R Lyu; N Glick; L Russell; S Mohapatra; N Saghal; R A Weinstein; G Trenholme
Journal:  Clin Infect Dis       Date:  2003-02-27       Impact factor: 9.079

5.  Factors associated with unplanned hospital readmission among patients 65 years of age and older in a Medicare managed care plan.

Authors:  E R Marcantonio; S McKean; M Goldfinger; S Kleefield; M Yurkofsky; T A Brennan
Journal:  Am J Med       Date:  1999-07       Impact factor: 4.965

6.  Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

Authors:  Cheol-In Kang; Sung-Han Kim; Wan Beom Park; Ki-Deok Lee; Hong-Bin Kim; Eui-Chong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

7.  The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.

Authors:  Sara E Cosgrove; Youlin Qi; Keith S Kaye; Stephan Harbarth; Adolf W Karchmer; Yehuda Carmeli
Journal:  Infect Control Hosp Epidemiol       Date:  2005-02       Impact factor: 3.254

8.  Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome.

Authors:  Scott E Cowie; Irene Ma; Susan K Lee; R Matthew Smith; York N Hsiang
Journal:  Vasc Endovascular Surg       Date:  2005 Jul-Aug       Impact factor: 1.089

9.  Identifying groups at high risk for carriage of antibiotic-resistant bacteria.

Authors:  Jon P Furuno; Jessina C McGregor; Anthony D Harris; Judith A Johnson; Jennifer K Johnson; Patricia Langenberg; Richard A Venezia; Joseph Finkelstein; David L Smith; Sandra M Strauss; Eli N Perencevich
Journal:  Arch Intern Med       Date:  2006-03-13

10.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

View more
  14 in total

1.  The Likelihood of Hospital Readmission Among Patients With Hospital-Onset Central Line-Associated Bloodstream Infections.

Authors:  Carolyn J Khong; James Baggs; David Kleinbaum; Ronda Cochran; John A Jernigan
Journal:  Infect Control Hosp Epidemiol       Date:  2015-05-20       Impact factor: 3.254

2.  The Impact of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infections on Postdischarge Health Care Costs and Utilization across Multiple Health Care Systems.

Authors:  Richard E Nelson; Makoto Jones; Chuan-Fen Liu; Matthew H Samore; Martin E Evans; Vanessa W Stevens; Thomas Reese; Michael A Rubin
Journal:  Health Serv Res       Date:  2018-10-09       Impact factor: 3.402

3.  Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates.

Authors:  Shruti K Gohil; Rupak Datta; Chenghua Cao; Michael J Phelan; Vinh Nguyen; Armaan A Rowther; Susan S Huang
Journal:  Clin Infect Dis       Date:  2015-06-30       Impact factor: 9.079

4.  Association between prehospital vitamin D status and hospital-acquired Clostridium difficile infections.

Authors:  Sadeq A Quraishi; Augusto A Litonjua; Takuhiro Moromizato; Fiona K Gibbons; Carlos A Camargo; Edward Giovannucci; Kenneth B Christopher
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-02-03       Impact factor: 4.016

Review 5.  Readmission in Cirrhosis: a Growing Problem.

Authors:  Sakkarin Chirapongsathorn; Jayant A Talwalkar; Patrick S Kamath
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

6.  Integrated MRSA-Management (IMM) with prolonged decolonization treatment after hospital discharge is effective: a single centre, non-randomised open-label trial.

Authors:  Bernhard Jahn; Trudy M Wassenaar; Annemarie Stroh
Journal:  Antimicrob Resist Infect Control       Date:  2016-06-14       Impact factor: 4.887

7.  Mortality, Hospital Costs, Payments, and Readmissions Associated With Clostridium difficile Infection Among Medicare Beneficiaries.

Authors:  Edward M Drozd; Timothy J Inocencio; Shamonda Braithwaite; Dayo Jagun; Hemal Shah; Nicole C Quon; Kelly C Broderick; Joseph L Kuti
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2015-11-02

8.  Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis.

Authors:  Sakkarin Chirapongsathorn; Chayakrit Krittanawong; Felicity T Enders; Richard Pendegraft; Kristin C Mara; Bijan J Borah; Sue L Visscher; Conor G Loftus; Vijay H Shah; Jayant A Talwalkar; Patrick S Kamath
Journal:  Hepatol Commun       Date:  2018-01-18

9.  The Effect of Liaison Nurse Service on Patient Outcomes after Discharging From ICU: a Randomized Controlled Trial.

Authors:  Zeinab Tabanejad; Marzieh Pazokian; Abbas Ebadi
Journal:  J Caring Sci       Date:  2016-09-01

10.  Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.

Authors:  Jason P Burnham; Jennie H Kwon; Margaret A Olsen; Hilary M Babcock; Marin H Kollef
Journal:  Infect Control Hosp Epidemiol       Date:  2017-12-17       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.